TP53 and neoplasm: These organoids were engineered to carry mutations of the tumor suppressor genes p53, NF1, and PTEN, together with GFP that allowed us to monitor tumor growth over time in the presence of dihydroartemisinin, 5‐ALA, or a combination of both.